BIM
AXDX

BlackRock Investment Management’s Accelerate Diagnostics AXDX Stock Holding History

BlackRock Investment Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.78M Buy
8,593
+2
+0% +$475 ﹤0.01% 2293
2016
Q3 		$2.34M Sell
8,591
-588
-6% -$130K ﹤0.01% 2027
2016
Q2 		$1.32M Buy
9,179
+484
+6% +$64.9K ﹤0.01% 2422
2016
Q1 		$1.25M Buy
8,695
+1,375
+19% +$194K ﹤0.01% 2339
2015
Q4 		$1.57M Buy
7,320
+56
+0.8% +$10.2K ﹤0.01% 2252
2015
Q3 		$1.18M Sell
7,264
-77
-1% -$16.7K ﹤0.01% 2485
2015
Q2 		$1.9M Buy
7,341
+1,114
+18% +$266K ﹤0.01% 2281
2015
Q1 		$1.4M Buy
6,227
+65
+1% +$13.6K ﹤0.01% 2287
2014
Q4 		$1.18M Sell
6,162
-27
-0.4% -$5.78K ﹤0.01% 2431
2014
Q3 		$1.33M Buy
6,189
+2
+0% +$389 ﹤0.01% 2310
2014
Q2 		$1.61M Buy
6,187
+3,104
+101% +$678K ﹤0.01% 2259
2014
Q1 		$672K Buy
3,083
+45
+1% +$6.67K ﹤0.01% 2789
2013
Q4 		$371K Sell
3,038
-22
-0.7% -$2.94K ﹤0.01% 3094
2013
Q3 		$410K Buy
3,060
+426
+16% +$38K ﹤0.01% 3012
2013
Q2 		$214K Buy
+2,634
New +$196K ﹤0.01% 3150

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BlackRock Investment Management's AXDX Position: Q4 2016 in Review

BlackRock Investment Management increased its Accelerate Diagnostics (AXDX) stake by 0.02% in Q4 2016, buying an estimated $475 and bringing the position to 8,593 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2293.

BlackRock Investment Management first reported a position in AXDX in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.34M in Q3 2016. 109 funds tracked by Wall St. Rank hold AXDX as of Q4 2016.

  • BlackRock Investment Management held 8,593 shares of Accelerate Diagnostics worth $1.78M as of Q4 2016.
  • BlackRock Investment Management bought 2 Accelerate Diagnostics shares in Q4 2016, an estimated $475.
  • Accelerate Diagnostics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2293 holding.
  • BlackRock Investment Management first reported a position in Accelerate Diagnostics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Accelerate Diagnostics position peaked at $2.34M in Q3 2016.
  • 109 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.